Recombinant Anti-Beta-galactosidase (Clone 13R4)
Applications | FC, WB |
Reactivities | Escherichia coli |
Recombinant Anti-Beta-galactosidase (Clone 13R4)
Applications | FC, WB |
Reactivities | Escherichia coli |
Recombinant Anti-Beta-galactosidase (Clone 13R4)
Applications | FC, WB |
Reactivities | Escherichia coli |
Recombinant Anti-Beta-galactosidase (Clone 13R4)
Applications | FC, WB |
Reactivities | Escherichia coli |
Recombinant Anti-Beta-galactosidase (Clone 13R4)
Applications | FC, WB |
Reactivities | Escherichia coli |
Recombinant Anti-Beta-galactosidase (Clone 13R4)
Applications | FC, WB |
Reactivities | Escherichia coli |
Anti-TIGIT [AET2010], Human IgG1, lambda
Applications | ELISA, FC |
Reactivities | Human |
Recombinant Anti-PD-L1 (Clone 332M7)
Applications | Bl, FC |
Reactivities | Human, Mouse, Monkey |
Recombinant Anti-SFMBT1 (Clone RAB-C396)
Applications | ChIP, ELISA |
Reactivities | Human |
Recombinant Anti-SUV420H2 (Clone RAB-C409)
Applications | ChIP, ELISA |
Reactivities | Human |
Recombinant Anti-FOXP2 (Clone RAB-S249)
Applications | ELISA, FC |
Reactivities | Human |
Recombinant Anti-PRMT3 (Clone RAB-C372)
Applications | ChIP, ELISA |
Reactivities | Human |
Recombinant Anti-Covid-19 & SARS-CoV Nucleoprotein (Clone CR3018 (03-018))
Applications | ELISA, IF |
Reactivities | SARS-CoV |
Recombinant Anti-Covid-19 & SARS-CoV Nucleoprotein (Clone CR3009 (03-009))
Applications | ELISA, IF |
Reactivities | SARS-CoV |
Recombinant Anti-Covid-19 & SARS-CoV Nucleoprotein (Clone CR3009 (03-009))
Applications | ELISA, IF |
Reactivities | SARS-CoV |
Recombinant Anti-Covid-19 & SARS-CoV Nucleoprotein (Clone CR3018 (03-018))
Applications | ELISA, IF |
Reactivities | SARS-CoV |